Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
India · Delayed Price · Currency is INR 365.35
+5.55 (1.54%)
Jul 31, 2026, 3:29 PM IST
NSE:INDRAMEDCO Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 2,633 | 614.8 | 616 | 522.6 | 417.4 |
Short-Term Investments | - | 2,571 | 1,603 | 739.5 | 242.7 |
Cash & Short-Term Investments | 2,633 | 3,186 | 2,219 | 1,262 | 660.1 |
Cash Growth | -17.36% | 43.61% | 75.78% | 91.20% | 164.89% |
Accounts Receivable | 1,122 | 845.6 | 642.6 | 746.2 | 481.3 |
Other Receivables | 100.7 | 12.3 | 6.1 | 4 | 214.5 |
Receivables | 1,222 | 857.9 | 648.7 | 750.2 | 695.8 |
Inventory | 78.6 | 69.9 | 75.3 | 84.5 | 99.9 |
Prepaid Expenses | - | 127.5 | 101.8 | 100.8 | 89.4 |
Other Current Assets | 232 | 70.1 | 35.5 | 33.2 | 29.1 |
Total Current Assets | 4,166 | 4,311 | 3,080 | 2,231 | 1,574 |
Property, Plant & Equipment | 3,673 | 3,600 | 3,464 | 2,766 | 2,752 |
Long-Term Investments | 2,035 | 549.2 | 605.2 | 455.1 | 230.1 |
Other Intangible Assets | 3.4 | 5.9 | 10.5 | 9.6 | 17.1 |
Other Long-Term Assets | 36.6 | 49.9 | 73.3 | 89.7 | 44.1 |
Total Assets | 9,914 | 8,516 | 7,232 | 5,551 | 4,617 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 1,282 | 490 | 706.4 | 588.7 | 390.9 |
Accrued Expenses | 60.4 | 854.9 | 694.3 | 534.9 | 414.9 |
Current Portion of Leases | 36.8 | 22.2 | 16.8 | 24.8 | 28.3 |
Current Income Taxes Payable | - | - | 5.8 | 44.2 | - |
Current Unearned Revenue | - | 81 | 88 | 69.4 | 68.7 |
Other Current Liabilities | 316.8 | 339 | 142.9 | 34.3 | 32.2 |
Total Current Liabilities | 1,696 | 1,787 | 1,654 | 1,296 | 935 |
Long-Term Leases | 331.8 | 305.4 | 322.7 | - | 24.8 |
Pension & Post-Retirement Benefits | - | - | - | - | 153.1 |
Long-Term Deferred Tax Liabilities | 203.7 | 153.9 | 197.2 | 199.8 | 231.9 |
Other Long-Term Liabilities | 278.9 | 303 | 280.7 | 260.8 | 17.9 |
Total Liabilities | 2,510 | 2,549 | 2,455 | 1,757 | 1,363 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 916.7 | 916.7 | 916.7 | 916.7 | 916.7 |
Retained Earnings | - | 5,180 | 3,983 | 3,018 | 2,386 |
Comprehensive Income & Other | 6,487 | -130 | -121.8 | -140.3 | -48.1 |
Shareholders' Equity | 7,404 | 5,967 | 4,778 | 3,795 | 3,254 |
Total Liabilities & Equity | 9,914 | 8,516 | 7,232 | 5,551 | 4,617 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 368.6 | 327.6 | 339.5 | 24.8 | 53.1 |
Net Cash (Debt) | 2,264 | 2,858 | 1,879 | 1,237 | 607 |
Net Cash Growth | -20.78% | 52.12% | 51.86% | 103.84% | 254.76% |
Net Cash Per Share | 24.70 | 31.18 | 20.50 | 13.50 | 6.62 |
Filing Date Shares Outstanding | 91.65 | 91.67 | 91.67 | 91.67 | 91.67 |
Total Common Shares Outstanding | 91.65 | 91.67 | 91.67 | 91.67 | 91.67 |
Working Capital | 2,470 | 2,524 | 1,426 | 934.5 | 639.3 |
Book Value Per Share | 80.78 | 65.09 | 52.12 | 41.39 | 35.50 |
Tangible Book Value | 7,400 | 5,961 | 4,767 | 3,785 | 3,237 |
Tangible Book Value Per Share | 80.75 | 65.02 | 52.00 | 41.29 | 35.31 |
Buildings | - | 1,998 | 1,988 | 1,929 | 1,898 |
Machinery | - | 3,190 | 3,247 | 2,855 | 2,603 |
Construction In Progress | - | 325.2 | 4.7 | 25.3 | - |